Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment
Clinical trial NCT01104662 · TERMINATED
Trial details
- NCT number
- NCT01104662
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-19
- Primary completion
- 2012-06-12
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.